Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel)

Standalone Modules

Module 8 - Digitalisation, Software and Cybersecurity

 

Content

Module 8 focuses on the regulatory framework for medical device software. It provides an overview of the software development lifecycle and the management of software quality. The module additionally covers cybersecurity and the regulation of devices based on artificial intelligence.

Learning objectives

Once you have successfully completed this module, participants understand the regulatory framework for medical device software, cybersecurity and artificial intelligence (AI), the software lifecycle processes, the role of software technologies in the medical device industry and the issues pertaining to their use, and the terminology, principles, application, threats and opportunities of AI and Machine Learning in the medical device field. 

Learning content

Module Digitalisation and Cybersecurity includes the regulatory framework for medical device software, cybersecurity and AI, Software Lifecycle Processes according to IEC 62304 and IEC 82304, disruptive technologies and digitalization, software and cybersecurity in the medical device field, cryptography, Cloud Computing and Software Development for connected devices, and Software Developemt methodology for connected devices. It also involves an understanding for the modern software develop-ment and AI and Machine Learning and big data: impact and approaches.

Start & Duration

Module 8 starts in October each year. 
The completion takes approximately 8 weeks.

Credits

3 ECTS

Fee

The cost of this standalone module is 3'150.– SFr.

Reference

03.008

 

Module Leaders

System Analyst, Cybersecurity expert, PROREGIA AG

Dr. Larissa Naber

Medical Device Software and QMS Lead, Senior Consultant at QUAREGIA

Peter Roka

Peter Roka holds a Master's degree in Biomedical Engineering and a Bachelor's degree in Electrical Engineering. With over nine years of experience in Medical Technologyhe specialized in product development and regulatory compliance, with a focus on software. In his current role as a Senior Quality and Regulatory Consultant, Peter guides various organizations through complex regulatory landscapes, advancing healthcare technology worldwide.

Founder & CEO at QUAREGIA GmbH and PROREGIA AG

Mathias Eng

Mathias T. Eng is an expert for quality management systems and medical device regulations. In 2019 T. Eng founded QUAREGIA GmbH and in 2020 he founded PROREGIA AG. At QUAREGIA Mathias T. Eng provides quality management- and regulatory affairs services for medical devices, in-vitro diagnostic devices, combination products, medical device software, cybersecurity and artificial intelligence.